Scientific illustration showing intestinal tuft cells signaling the brain via acetylcholine, serotonin, and the vagus nerve to suppress appetite during parasitic infections.
Scientific illustration showing intestinal tuft cells signaling the brain via acetylcholine, serotonin, and the vagus nerve to suppress appetite during parasitic infections.
Hoton da AI ya samar

Intestinal cells signal brain to curb hunger during parasitic infections

Hoton da AI ya samar

A team led by David Julius, the 2021 Nobel Prize winner in Medicine, has described the molecular mechanism by which intestinal tuft cells signal the brain to suppress appetite during parasitic infections. Published today in Nature, the study identifies communication via acetylcholine and serotonin that activates the vagus nerve. The finding could aid treatments for conditions like irritable bowel syndrome.

David Julius's team at the University of California, San Francisco (UCSF), has traced the pathway linking the intestinal immune system to the brain during parasitic worm infections. Tuft cells detect parasites via succinate and release acetylcholine in two phases: an initial brief burst and a sustained release after full immune response. This acetylcholine stimulates enterochromaffin (EC) cells, which release serotonin and activate vagus nerve fibers to the brain, causing appetite loss akin to gastroenteritis, according to the study published Wednesday in Nature. First author Koki Tohara explained: “Tuft cells do something neurons do, but through a completely different mechanism,” using acetylcholine without typical neuronal machinery. Julius noted: “The gut waits to confirm the threat is real and persistent before telling the brain to change your behavior,” explaining delayed symptoms. Coauthor and UCSF immunologist Richard Locksley highlighted interest in how these non-synaptically connected cells alter behavior. Mouse experiments confirmed the mechanism: animals with intact tuft cells ate less, while genetically modified ones lacking acetylcholine production maintained normal intake. The authors suggest applications for managing infection responses and conditions like food intolerances or chronic visceral pain, as tuft cells exist in other epithelia like airways. Spanish experts such as Félix Viana from the Alicante Institute of Neurosciences call it “interesting” and relevant for defenses in other tissues, while José Luis Trejo from the Cajal Neuroscience Center views it as a “sensory interface” with therapeutic potential.

Abin da mutane ke faɗa

Initial reactions on X to the Nature study on intestinal tuft cells signaling the brain to curb hunger during parasitic infections are positive and informative. Nutritionists and scientists shared summaries in English and Spanish, highlighting the role of acetylcholine and serotonin via the vagus nerve. Posts linked to the study and ScienceDaily, noting potential IBS treatment implications. Some connected findings to vagus nerve function and gut-brain axis.

Labaran da ke da alaƙa

Illustration depicting FGF21 hormone activating hindbrain circuit in obese mouse to drive weight loss via boosted metabolism, highlighting NTS, AP, and PBN.
Hoton da AI ya samar

Researchers map hindbrain circuit through which hormone FGF21 drives weight loss in obese mice

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

University of Oklahoma scientists report that the hormone FGF21 reduces body weight in obese mice by acting on a hindbrain pathway—centered on the nucleus of the solitary tract and area postrema—that relays signals to the parabrachial nucleus. The team says the mechanism overlaps anatomically with brain regions implicated in GLP-1 drugs, but appears to promote weight loss mainly by increasing metabolic rate rather than primarily suppressing food intake.

Astrocytes—cells once widely described primarily as neuronal support—may be key intermediaries in how the brain translates a post-meal rise in glucose into satiety signals, according to a study published April 6, 2026, in the Proceedings of the National Academy of Sciences.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Researchers at the Massachusetts Institute of Technology report that intelectin-2, a carbohydrate-binding lectin found in the gastrointestinal tract, can both crosslink mucus components to reinforce the gut’s protective barrier and bind certain bacteria, restricting their growth and reducing viability—findings that may inform future approaches to drug-resistant infections and inflammatory bowel disease.

Researchers at Nagoya University report that two common gut microbes can work together to break down the colon’s protective mucus layer, leaving stool dry and difficult to pass—an effect that standard laxatives may not address. The team also found higher levels of these bacteria in people with Parkinson’s disease, who often experience constipation decades before motor symptoms, and showed in mice that disabling a key bacterial enzyme prevented constipation.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Scientists at Cedars-Sinai Medical Center report that a subset of astrocytes located away from a spinal cord injury can help drive repair in mice by releasing the protein CCN1, which alters microglia metabolism to improve cleanup of lipid-rich nerve debris. The work, published in Nature, also found evidence of a similar CCN1-linked response in human spinal cord tissue from people with multiple sclerosis.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi